Skip to content
EntityQ7280139· pop 5· linked from 113 articles

Radezolid (INN, codenamed RX-1741) is a novel oxazolidinone antibiotic being developed by Melinta Therapeutics, Inc. for the treatment of bacterial acne.

Wikidata facts

Mass
438.182
Show 4 more facts
chemical formula
C₂₂H₂₃FN₆O₃
canonical SMILES
CC(=O)NCC1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F
isomeric SMILES
CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)C3=CC=C(C=C3)CNCC4=NNN=C4)F
subject has role
antibiotic
Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

2 sections
Contents
  • References
  • Further reading

{{Drugbox | IUPAC_name = N-{[(5S)-3-(2-fluoro-4′-{[(1H-1,2,3-triazol-5-ylmethyl)amino]methyl}biphenyl-4-yl)-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide | image = Radezolid.svg | image_class = skin-invert-image | alt = Skeletal formula of radezolid

| tradename = | legal_status = Investigational | routes_of_administration = Intravenous infusion, oral

Excerpted from Wikipedia’s “radezolid” article, available under the CC BY-SA 4.0 licence.

Available in 5 languages

via Wikidata sitelinks · CC0